Averion

Averion Announces Merger

A Global Biopharmaceutical Development Service Organization Is Formed From Four Portfolio Companies: Averion International, Trio Clinical Research, Fulcrum Pharma and ClinResearch/ADDPLAN.  Learn More. 

 

Clinical Consulting

Vaccines

Clinical Trial RescueCase Study 2

Many issues can arise durting the course of a clinical trial; timelines don’t get met, data isn’t cleaned properly, resources get taken away from the study team, the regulatory agency halts the trial for lack of expected results, etc. Sometimes a fresh outlook can put a trial back on track. Averion is very experienced in rescuing a clinical trial/program.

The most frequent situations where we are called upon to rescue a trial include:

Another opinion:

In some cases the data analyses does not turn out as expected. Because the data was only analyzed with the data from the current trial, the analysis did not pick up the same trends that were seen when the results were combined with previous studies. In this case, a fresh perspective is needed.

Work Overload:

This happens to everyone. Timelines get accelerated,  resources aren't available and same amount and quality of work is expected of the study team. Sometimes, it just takes additional help to meet the timelines.

Poor Performance:

Despite the best of relationships, vendor performance can decline, project turnover increases and the new project team just doesn’t understand. It may be time for a new vendor.

Inadequate performance, whether in monitoring, project management, data collection and/or analysis, can jeopardize a study and set back the entire clinical development program.  Proper corrective action and strategy can often save a rough situation. Averion assists its clients with emergency site monitoring, immediate data management assistance, creative post hoc analysis, critical thinking and more.